| Medical and Health Sciences | Lifetime | 130 | US 74 | 99.99 |
| Medical and Health Sciences | 2021-2025 | 283 | US 100 | 99.94 |
| Nephrology | Lifetime | 4 | US 2 | 99.97 |
| Epidemiology | Lifetime | 80 | US 40 | 99.88 |
| Critical Care and Intensive Care Medicine | Lifetime | 16 | US 9 | 99.68 |
| Surgery | Lifetime | 759 | US 404 | 99.29 |
| Emergency Medicine | Lifetime | 134 | US 73 | 98.95 |
| Nephrology | 2021-2025 | 7 | US 1 | 99.85 |
| Epidemiology | 2021-2025 | 122 | US 37 | 99.21 |
| Surgery | 2021-2025 | 830 | US 319 | 92.66 |
| Immunology | 2021-2025 | 528 | US 191 | 85.10 |
| Sepsis Diagnosis and Treatment | Lifetime | 3 | US 1 | 99.98 |
| Acute Kidney Injury Research | Lifetime | 2 | US 1 | 99.97 |
| Chronic Kidney Disease and Diabetes | Lifetime | 7 | US 5 | 99.90 |
| Hemodynamic Monitoring and Therapy | Lifetime | 5 | US 2 | 99.89 |
| Renal function and acid-base balance | Lifetime | 3 | US 1 | 99.96 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 3 | US 2 | 99.96 |
| Cardiac Arrest and Resuscitation | Lifetime | 26 | US 12 | 99.85 |
| Muscle and Compartmental Disorders | Lifetime | 3 | US 2 | 99.93 |
| Dialysis and Renal Disease Management | Lifetime | 39 | US 18 | 99.74 |
| Electrolyte and hormonal disorders | Lifetime | 48 | US 26 | 99.17 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 272 | US 144 | 99.34 |
| Poisoning and overdose treatments | Lifetime | 26 | US 10 | 99.03 |
| Respiratory Support and Mechanisms | Lifetime | 248 | US 94 | 99.26 |
| Immune Response and Inflammation | Lifetime | 309 | US 148 | 99.18 |
| Ion Transport and Channel Regulation | Lifetime | 120 | US 61 | 98.30 |
| Inflammation biomarkers and pathways | Lifetime | 30 | US 13 | 97.40 |
| Potassium and Related Disorders | Lifetime | 73 | US 47 | 98.30 |
| Mechanical Circulatory Support Devices | Lifetime | 451 | US 267 | 98.11 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 689 | US 372 | 98.13 |
| COVID-19 Clinical Research Studies | Lifetime | 1,000 | US 236 | 96.79 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 459 | US 172 | 97.68 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 760 | US 328 | 97.92 |
| Organ Donation and Transplantation | Lifetime | 445 | US 235 | 96.84 |
| Cardiac Ischemia and Reperfusion | Lifetime | 613 | US 275 | 96.51 |
| Thermal Regulation in Medicine | Lifetime | 436 | US 173 | 93.68 |
| Nosocomial Infections in ICU | Lifetime | 760 | US 250 | 93.40 |
| Vitamin K Research Studies | Lifetime | 472 | US 201 | 89.12 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 3 | US 1 | 99.83 |
| Acute Kidney Injury Research | 2021-2025 | 2 | US 1 | 99.86 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 22 | US 9 | 99.40 |
| Renal function and acid-base balance | 2021-2025 | 4 | US 1 | 97.28 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 13 | US 6 | 98.63 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 30 | US 8 | 98.43 |
| Immune Response and Inflammation | 2021-2025 | 31 | US 11 | 96.89 |
| Muscle and Compartmental Disorders | 2021-2025 | 13 | US 3 | 96.62 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 423 | US 140 | 96.13 |
| Dialysis and Renal Disease Management | 2021-2025 | 337 | US 75 | 93.96 |
| Renal and Vascular Pathologies | 2021-2025 | 703 | US 182 | 79.09 |
| S100 Proteins and Annexins | 2021-2025 | 524 | US 117 | 69.59 |
| Thermal Regulation in Medicine | 2021-2025 | 747 | US 158 | 59.93 |
| Electrolyte and hormonal disorders | 2021-2025 | 987 | US 241 | 58.67 |
| Poisoning and overdose treatments | 2021-2025 | 713 | US 332 | 58.59 |
